Headline
The latest stories from AHA Today.
The Federal Communications Commission adopted a report and order implementing changes to the COVID-19 Telehealth Program under the Consolidated Appropriations Act, which authorized an additional $249.95 million in funding for the program.
The Department of Health and Human Services updated its Provider Relief Fund FAQs related to “Terms and Conditions,” “Ownership Structures and Financial Relationships,” and “Use of Funds.”
The Centers for Medicare & Medicaid Services released an article informing all Medicare providers and suppliers who requested and received COVID-19 Accelerated and Advance Payments that it began recovering those payments March 30, depending on the one-year anniversary of their first payment.
The Department of Health and Human Services launched a nationwide network of trusted voices to encourage vaccinations and increase vaccine confidence.
On this Advancing Health podcast, listen to how Texas Health Resources pulled together a collaborative team of leaders across the system to bridge performance gaps in clinical documentation, claims denials management and coding.
“Unprecedented” conditions imposed by the California attorney general on Huntington Hospital’s proposed affiliation with Cedars-Sinai would jeopardize the community’s access to critical clinical programs and services and disadvantage Huntington and its patients compared with other hospitals in the…
The AHA and American Society of Health-System Pharmacists urged the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”
New information sharing requirements for health information technology take effect April 5 under an interim final rule released last year by the Office of the National Coordinator for Health Information Technology.
AHA urged the Medicare Payment Advisory Commission to reconsider certain proposed changes to Medicare payment for indirect medical education and separately payable outpatient drugs, which the commission could vote on later this week.
The Food and Drug Administration has launched a webpage on the impact of viral mutations on COVID-19 tests, including recommendations for clinical laboratory staff and health care providers using the tests.